Testing effectiveness (Phase 2)Ended earlyNCT01856257
What this trial is testing
Open-Label Phase 2 Trial of a Steroid-Free, CNI-Free, Belatacept-Based Immunosuppressive Regimen
Who this might be right for
Primary Renal Allograft CandidateKidney Transplantation
National Institute of Allergy and Infectious Diseases (NIAID) 71